James M. Inhofe sold CRSP

January 5, 2021 · STOCK Act disclosure

Senator James M. Inhofe (Republican-OK) sold CRISPR Therapeutics AG, a stock transaction, valued at $1,001 - $15,000. The trade took place on January 5, 2021 and was disclosed on January 15, 2021 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.

Type

Sell

Amount

$1,001 - $15,000

Transaction date

January 5, 2021

Disclosed

January 15, 2021

MemberJames M. Inhofe

ChamberSenate

Party / StateRepublican · OK

AssetCRISPR Therapeutics AG (CRSP)

Security typeStock

OwnerSelf

Amount range$1,001 - $15,000

Transaction dateJanuary 5, 2021

Filing dateJanuary 15, 2021

AmendmentNo

Asset description

CRISPR Therapeutics AG

View the original STOCK Act disclosure